Therapeutic Effect of Exendin-4, a Long-Acting Analogue of Glucagon-Like Peptide-1 Receptor Agonist, on Nerve Regeneration after the Crush Nerve Injury

Table 1

Electrophysiological study at 4 weeks after crush (𝑛=6 in each group).

Group	CMAP	Latency
	Mean [SD] (mV)	Mean [SD] (ms)
Crush	8.38 [2.43]	3.53 [0.31]
Crush + exendin-4	11.87 [1.56]	2.87 [0.46]^∗∗
Exendin-4	15.30 [4.69]	1.46 [0.10]^∗∗
Sham operation	16.22 [4.59]	1.45 [0.09]^∗∗

^∗∗𝑃<0.01 compared with crush group.